Considerations in developing medical countermeasures against chemical ocular toxicity

被引：6
|
作者：
Yeung, David T. [1 ]
Araj, Houmam [2 ]
Harper, Jill R. [3 ]
Platoff, Gennady E., Jr. [4 ]
机构：
[1] NIAID, Dept Hlth & Human Serv, NIH, 5601 Fishers Lane,1G58, Bethesda, MD 20892 USA
[2] US Dept HHS, NEI, NTH, 6700B Rockledge Dr,Suite 3400, Bethesda, MD 20817 USA
[3] NIAID, US Dept HHS, NIH, 31 Ctr Dr,MSC 2520, Bethesda, MD 20892 USA
[4] US Dept HHS, NIAID, NIH, 5601 Fishers Lane,1G55, Bethesda, MD 20892 USA
来源：
TOXICOLOGY LETTERS | 2020年 / 334卷
关键词：
Ocular toxicity; Medical countermeasures; Chemical threats; CCRP; Vesicants; AGENTS;
D O I：
10.1016/j.toxlet.2020.09.004
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
The Chemical Countermeasures Research Program (CCRP) was established in 2006 by the National Institute of Allergy and Infectious Diseases (NIAID/NIH) on behalf of the National Institutes of Health Office of the Director (NIH OD). It is a trans-NIH initiative to expedite the discovery and early development of medical countermeasures (MCMs) that can reduce mortality and serious morbidity during and after large consequence public health emergency involving the deliberate or accidental large-scale release of highly toxic chemicals (HTCs).
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
12345